跳至主要内容
临床试验/IRCT20200905048630N4
IRCT20200905048630N4尚未招募3 期

The effect of alpha lipoic acid administration on the outcomes of assisted reproductive therapy in patients with polycystic ovarian syndrome

Bandare-abbas University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 37 years(—)
性别
Female

入选标准

  • Women with polycystic ovary syndrome according to the Rotterdam criteria
  • Women of reproductive age between 18 and 37 years
  • Candidate for in vitro fertilization
  • No endometriosis
  • Absence of hydrosalpinx

排除标准

  • Secondary causes of obesity (hypothyroidism, Cushing's syndrome)
  • High grade endometriosis III and IV
  • Thyroid diseases
  • Salpingitis and hydrosalpinx
  • Congenital adrenal hyperplasia
  • Hyperprolactinemia
  • Ovarian secretory tumors
  • Receipt of OCPs (steroids or other drugs that affect ovarian function, insulin sensitivity, and lipid metabolism) in the past 3 months, except for standardized PCOS treatment
  • Lupus and autoimmune diseases
  • Systemic diseases such as hyperlipidemia and cardiovascular metabolic syndrome
  • Severe male factor, especially non-obstructive azoospermia (sperm count less than 5 million/ml)
  • Receive insulin

研究者

发起方
Bandare-abbas University of Medical Sciences

相似试验